| 000 | 01640 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518095016.0 | ||
| 264 | 0 | _c20201027 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1477-092X | ||
| 024 | 7 |
_a10.1177/1078155220915956 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHanna, Kirollos S | |
| 245 | 0 | 0 |
_aThe role of Bruton's tyrosine kinase inhibitors in the management of mantle cell lymphoma. _h[electronic resource] |
| 260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cJul 2020 |
||
| 300 |
_a1190-1199 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAgammaglobulinaemia Tyrosine Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzamides _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aLymphoma, Mantle-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 700 | 1 | _aCampbell, Maren | |
| 700 | 1 | _aHusak, Alex | |
| 700 | 1 | _aSturm, Sabrina | |
| 773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 26 _gno. 5 _gp. 1190-1199 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155220915956 _zAvailable from publisher's website |
| 999 |
_c30846818 _d30846818 |
||